Biotechnology Stocks I Performance Guide: Ocular Therapeutix, Inc. (OCUL)
OCUL has no dividends.
Table and Chart of OCUL Performance
See what a $1,000 investment in OCUL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| OCUL Returns | |
|---|---|
| Start Date | Aug-29-2014 |
| Start Price | $16.47 |
| End Date | May-07-2024 |
| End Price | $5.93 |
| # Prices | 118 |
| Min Date | Nov-30-2023 |
| Min Price | $2.48 |
| Max Date | Mar-31-2015 |
| Max Price | $41.99 |
| Total Return | -64.00% |
| Annualized Return | -9.87% |
| Current Value of $1,000 Purchase | $360 |
| Number Returns | 6,903 |
| Average Return | -5.62% |
| Number Profitable Returns | 2,221 |
| Percent Profitable Returns | 32.17% |
| Number Unprofitable Returns | 4,682 |
| Percent Unprofitable Returns | 67.83% |
| Profitable to Unprofitable Returns Ratio | 0.47 |
| OCUL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $897,411,000 |
| Beta | 1.322 | Price to Sales | 20.32 |
| Earnings per Share | $-1.0200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 13.03 |
| PRICE DATA | |
| 52 Week High | $11.31 |
| 52 Week Low | $1.995 |
| Analyst Target Price | $15.5 |
| 50-Day Moving Average | $8.2 |
| 200-Day Moving Average | $4.94 |
| FINANCIAL DATA | |
| Revenue per Share | $0.732 |
| Revenue | $58,443,000 |
| Profit Margin | -138.1% |
| Return on Equity | -127.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
OCUL Compare Returns with S&P 500
OCUL Trendline Chart
OCUL Moving Average Chart
OCUL Stock Return Map - See Patterns of Gains and Losses
OCUL Stock Returns/Purchase Dates